Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DR26FZ62R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $37,324
Award facts
- Contract value 100% obligated
- $37,323.54 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $37,323.54 for Dupixent 300 mg/2 ml pen 2ml units on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed price, non-set-aside contract represents a direct purchase under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX). The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent (dupilumab) is a biologic injectable medication used to treat conditions such as eczema, asthma, and allergic rhinitis, and its procurement supports the pharmaceutical supply chain for military and federal healthcare systems.
This delivery order is issued under AmerisourceBergen's broader $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical running through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a prime vendor for the Defense Logistics Agency, AmerisourceBergen supplies a wide range of pharmaceutical products, medical devices, and healthcare commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's federal contracting history demonstrates consistent capability to meet competitive federal procurement requirements across multiple therapeutic domains and delivery scales.
Quick answers
Who was awarded contract SPE2DR26FZ62R?
SPE2DR26FZ62R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 4, 2025.
How much is contract SPE2DR26FZ62R worth?
The government has obligated $37,324 on SPE2DR26FZ62R.
Is contract SPE2DR26FZ62R an order under another contract?
Yes. SPE2DR26FZ62R is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FZ62R competed?
The extent of competition for SPE2DR26FZ62R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award